Drug Product
Company Overview
About
Aggrega Pharma, LLC is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:France
Founded:2013
Employees:197
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval JKTYMS
PMDA · #APR-H0RC6C0E · 2018-05-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-RVT4RCCR
Issued: 2020-03-05
Expires: 2025-12-10
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-THDJME41
Issued: 2020-05-15
Expires: 2025-11-17
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-T0I40Q10
Issued: 2020-08-28
Expires: 2025-05-22
Health Canada GMP
Health Canada
Cert #: CERT-12RLONPX
Issued: 2020-12-16
Expires: 2025-01-04
Loading CDMO intelligence...
Key facts about Aggrega Pharma, LLC
- Aggrega Pharma, LLC is headquartered in France.
- Aggrega Pharma, LLC was founded in 2013.
- Aggrega Pharma, LLC has 197 employees.
- Aggrega Pharma, LLC's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Aggrega Pharma, LLC
Directory pages this company appears in, each with the full list of matching manufacturers.